Abstract
The diagnostic criteria for schizophrenia have historically been based predominantly on the so-called positive symptoms, i.e., delusions, hallucinations, thought disorganization. This is not to say that the significance of negative symptom psychopathology, i.e., deficits of affect, drive, interest, speech, and thought, has been minimized, but rather less well characterized and understood. Reported differences between positive and negative symptoms in their pharmacologic response (Csernansky et al. 1986; Huber et al. 1980; Johnstone et al. 1983; Kay and Opler 1987) and pathobiologic correlates have been interpreted as evidence that these symptom clusters reflect different pathophysiologic processes or substrates (Andreasen 1982; Andreasen and Olsen 1982; Andreasen et al. 1982; Crow 1980a, b). In addition, follow-up studies indicating that negative symptoms are associated with a more chronic course of illness and poorer outcomes have been taken as evidence that negative symptom psychopathology may reflect a specific subtype of schizophrenia (Carpenter et al. 1988; Crow 1985; Kay et al. 1986; Pogue-Geile and Harrow 1984).
This study was supported by NIMH grant (MH 41646) and a Research Scientist Development Award (MH 00537) to Dr. Lieberman and the Mental Health Clinical Research Center for the Study of Schizophrenia (MH 41960); MRI studies were performed in association with The Brain Morphometry and Image Analysis Center supported by a grant from the Helen and Irving Schneider Family.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Similar content being viewed by others
References
Andreasen NC (1982) Negative symptoms in schizophrenia: definition and reliability. Arch Gen Psychiatry 39:784–788
Andreasen NC (1983) The scale for the assessment of negative symptoms (SANS). University of Iowa, Iowa City
Andreasen NC, Olsen S (1982) Negative vs positive schizophrenia: definition and validation. Arch Gen Psychiatry 39:789–794
Andreasen NC, Olsen SA, Deenert JW, Smith MR (1982) Ventricular enlargement in schizophrenia: relationship to positive and negative symptoms. Am J Psychiatry 139:297–302
Andreasen NC, Flaum M, Swayze VW II, Tyrrel G, Arndt S (1990) Positive and negative symptoms in schizophrenia. A critical reappraisal. Arch Gen Psychiatry 47:615–621
Angrist B, Rotrosen J, Gershon S (1980) Differential effects of amphetamine and neuroleptics on positive vs negative symptoms in schizophrenia. Psychopharmacology (Berlin) 72:17–19
Angrist B, Peselow E, Rubinstein M et al. (1982) Partial improvement in negative schizophrenic symptoms after amphetamine. Psychopharmacology (Berlin) 78:128–130
Bogerts B, Ashtari M, Degreef G, Alvir JM, Bilder RM, Lieberman JA (1990) Reduced temporal limbic structure volumes on magnetic resonance images in first episode schizophrenia. Psychiatry Res 35:1–13
Carpenter WT Jr, Heinrichs DW, Alphs LD (1985) Treatment of negative symptoms. Schizophr Bull 11:440–452
Carpenter WT, Heinrichs DW, Wagman AMI (1988) Deficit and nondeficit forms of schizophrenia. The concept. Am J Psychiatry 145:578–583
Cox DR (1970) The analysis of binary data. Chapman and Hall, London
Cox DR (1972) Regression model and life tables. J R Stat Soc [B] 34:187–220
Crow TJ (1980a) Molecular pathology of schizophrenia: more than one disease process? Br Med J 280:66–68
Crow TJ (1980b) Positive and negative symptoms and the role of dopamine. Br J Psychiatry 137:383–386
Crow TJ (1985) The two-syndrome concept: origins and current status. Schizophr Bull 11:471–486
Csernansky JG, Brown K, Hollister LE (1986) Is there drug treatment for negative schizophrenic symptoms? Hosp Formul 21:790–792
Degreef G, Ashtari M, Bogerts B, Bilder RM, Jody DN, Alvir JM, Lieberman JA (1991) Temporal horn volumes measured from magnetic resonance images are correlated with symptoms of schizophrenia (in press)
Guy W (1976) Clinical global impression scale. In: EDCEU Assessment Manual. US Department of Health Education and Welfare, Washington DC, pp 281–222
Huber G, Gross G, Schüttler R, Linz M (1980) Longitudinal studies of schizophrenic patients. Schizophr Bull 6:592–605
Johnstone EC, Crow TJ, Ferrier IN et al. (1983) Adverse effects of anticholinergic medication on positive schizophrenic symptoms. Psychol Med 13:513–527
Kay SR, Opler LA (1987) The positive-negative dimension in schizophrenia: its validity and significance. Psychiatr Dev 2:79–103
Kay SR, Fiszbein A, Lindenmayer JP, Opler LA (1986) Positive and negative syndromes in schizophrenia as a function of chronicity. Acta Psychiatr Scand 74:507–518
Lewine RRJ (1981) Sex differences in schizophrenia: timing or subtypes? Psychol Bull 90:432–434
Lieberman JA, Kane JM, Gadaletta D, Ramos-Lorenz J, Bergmann K, Wegner J, Novacenko H (1985) Methylphenidate challenge tests and course of schizophrenia. Psychopharmacol Bull 21 (1) : 123–129
Lieberman J, Jody D, Geisler S, Vital-Herne J, Alvir J, Walsleben J, Woerner M (1989) Treatment outcome of first-episode schizophrenia. Psychopharmacol Bull 25:92–96
Lieberman J, Jody D, Alvir J, Ashtari M, Levy D, Bogerts B, Degreef G, Cooper T, Novacenko H (1991a) Brain morphology, dopamine and eye movement function in first episode schizophrenia (in press)
Lieberman J, Jody D, Geisler S, Szymanski S, Alvir J, Woerner M, Borenstein M (1991b) Time course and biologic correlates of treatment response in first episode schizophrenia (in press)
McGlashan TH, Bardenstein KK (1990) Gender differences in affective, schizoaffective and schizophrenic disorders. Schizophr Bull 16(2):312–329
Pogue-Geile MF, Harrow M (1984) Negative and positive symptoms in schizophrenia and depression: a follow up. Schizophr Bull 10:371–387
Seeman MV (1986) Current outcome in schizophrenia: women vs men. Acta Psychiatr Scand 73(6):609–617
Simpson GM, Angus JWS (1970) A rating scale for extrapyramidal side effects. Acta Psychiatr Scand [Suppl] 212:11–19
Simpson GM, Lee JH, Zoubek B et al. (1979) A rating scale for tardive dyskinesia. Psychopharmacology 64:171–179
Spitzer RL, Endicott J (1977) Schedule for affective disorders and schizophrenia (SADS), 3rd edn. NY State Psychiatric Institute Biometrics Division, New York
Spitzer RL, Endicott J (1978) Schedule for affective disorders and schizophrenia-change version, 3rd edn. NY State Psychiatric Institute Biometrics Division, New York
Spitzer RL, Endicott JE, Robins E (1978) Research diagnostic criteria for a selected group of functional disorders, 3rd edn. NY State Psychiatric Institute Biometrics Research, New York
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1991 Springer-Verlag Berlin Heidelberg
About this paper
Cite this paper
Lieberman, J.A. et al. (1991). Negative Symptoms in Schizophrenia: Relationship to Positive Symptoms and Outcome. In: Marneros, A., Andreasen, N.C., Tsuang, M.T. (eds) Negative Versus Positive Schizophrenia. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-76841-5_8
Download citation
DOI: https://doi.org/10.1007/978-3-642-76841-5_8
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-76843-9
Online ISBN: 978-3-642-76841-5
eBook Packages: Springer Book Archive